Continuous Intraarterial Nimodipine Infusion for the Treatment of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Retrospective, Single-Center Cohort Trial
BackgroundDelayed cerebral ischemia (DCI) occurs after aneurysmal subarachnoid hemorrhage (aSAH). Continuous intraarterial nimodipine infusion (CIAN) is a promising approach in patients with intracranial large vessel vasospasm (LVV). The objective of this retrospective single-center cohort study was...
Main Authors: | Andreas Kramer, Moritz Selbach, Thomas Kerz, Axel Neulen, Marc A. Brockmann, Florian Ringel, Carolin Brockmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2022.829938/full |
Similar Items
-
The curative effect of cinepazide maleate and nimodipine in the treatment of cerebral vasospasm after subarachnoid hemorrhage
by: Cui-fen LIU, et al.
Published: (2013-10-01) -
The Nimodipine-Sparing Effect of Perioperative Dexmedetomidine Infusion During Aneurysmal Subarachnoid Hemorrhage: A Prospective, Randomized, Controlled Trial
by: Chunguang Ren, et al.
Published: (2019-08-01) -
High Compliance with Scheduled Nimodipine Is Associated with Better Outcome in Aneurysmal Subarachnoid Hemorrhage Patients Cotreated with Heparin Infusion
by: Aaron Wessell, et al.
Published: (2017-06-01) -
Safety and Clinical Effects of Switching From Intravenous to Oral Nimodipine Administration in Aneurysmal Subarachnoid Hemorrhage
by: Jennifer Göttsche, et al.
Published: (2021-11-01) -
Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis
by: Guangzhi Hao, et al.
Published: (2022-09-01)